COLAIANNI, GRAZIANA
 Distribuzione geografica
Continente #
NA - Nord America 6.992
AS - Asia 2.866
EU - Europa 2.492
SA - Sud America 745
AF - Africa 192
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 13.301
Nazione #
US - Stati Uniti d'America 6.882
SG - Singapore 1.244
IT - Italia 821
CN - Cina 728
BR - Brasile 636
SE - Svezia 434
HK - Hong Kong 356
RU - Federazione Russa 344
DE - Germania 242
VN - Vietnam 183
CI - Costa d'Avorio 139
GB - Regno Unito 138
UA - Ucraina 124
FI - Finlandia 109
FR - Francia 95
IN - India 77
ID - Indonesia 58
CA - Canada 51
MX - Messico 42
AR - Argentina 40
BE - Belgio 34
JP - Giappone 29
NL - Olanda 29
PL - Polonia 26
TR - Turchia 26
ES - Italia 24
BD - Bangladesh 23
ZA - Sudafrica 20
IE - Irlanda 18
IQ - Iraq 17
AE - Emirati Arabi Uniti 15
PK - Pakistan 15
CO - Colombia 14
EC - Ecuador 13
AT - Austria 11
IR - Iran 11
PY - Paraguay 11
SA - Arabia Saudita 11
KR - Corea 10
PE - Perù 10
AU - Australia 8
CL - Cile 8
CZ - Repubblica Ceca 8
LT - Lituania 8
UZ - Uzbekistan 8
EG - Egitto 7
MA - Marocco 7
MY - Malesia 7
VE - Venezuela 7
JM - Giamaica 6
TH - Thailandia 6
TN - Tunisia 6
AZ - Azerbaigian 5
KE - Kenya 5
OM - Oman 5
PH - Filippine 5
UY - Uruguay 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
IL - Israele 4
JO - Giordania 4
BY - Bielorussia 3
DZ - Algeria 3
EU - Europa 3
GR - Grecia 3
KG - Kirghizistan 3
NO - Norvegia 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 13.301
Città #
Fairfield 806
Ashburn 795
Singapore 629
Woodbridge 568
Chandler 455
Houston 430
Bari 370
Hong Kong 354
Nyköping 350
Cambridge 346
Seattle 343
Ann Arbor 305
Wilmington 279
Jacksonville 276
Beijing 239
Dallas 204
Abidjan 139
New York 111
Roxbury 106
Nanjing 105
Lawrence 97
Los Angeles 89
Munich 82
Des Moines 72
Grumo Appula 66
Brooklyn 64
Inglewood 58
Ho Chi Minh City 55
Santa Clara 52
Boardman 46
Jakarta 46
Princeton 43
São Paulo 43
Hanoi 41
San Diego 37
Chicago 35
Brussels 34
Buffalo 33
Trani 33
London 32
Milan 32
Shenyang 30
Rome 29
Jiaxing 28
Tokyo 27
Dearborn 26
Dong Ket 25
Helsinki 24
Redwood City 24
Warsaw 24
Frankfurt am Main 23
Nanchang 23
Rio de Janeiro 23
Hebei 22
Mexico City 22
Pune 22
The Dalles 21
Changsha 19
Montreal 19
Moscow 19
Noicattaro 18
San Francisco 18
Dublin 17
Paris 17
Tianjin 17
Falls Church 16
Toronto 16
Turku 15
Columbus 14
Ankara 13
Council Bluffs 13
Orem 13
Poplar 13
Zhengzhou 13
Atlanta 12
Brasília 12
Campinas 12
Guangzhou 12
Nuremberg 12
Chennai 11
Johannesburg 11
Phoenix 11
Belo Horizonte 10
Boydton 10
Charlotte 10
Denver 10
Salt Lake City 10
Salvador 10
Shanghai 10
Stockholm 10
Baghdad 9
Boston 9
Falkenstein 9
Haiphong 9
Mumbai 9
Ningbo 9
Orta Nova 9
Ardabil 8
Guarulhos 8
Jinan 8
Totale 9.223
Nome #
Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission 245
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 192
Functions of vasopressin and oxytocin in bone mass regulation 192
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children 191
The myokine irisin increases cortical bone mass 189
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity 188
High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus 181
Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice 176
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects 176
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 174
Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin 168
An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases 158
Irisin levels correlate with bone mineral density in soccer players 157
Sclerostin stimulates angiogenesis in human endothelial cells 151
Mechanisms involved in childhood obesity-related bone fragility 149
Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass 145
Oxytocin receptor nuclear translocation mediates upregulation of osteoblast specific genes 143
Irisin and musculoskeletal health 141
A Novel Mechanism of Signal Transduction: Oxytocin Receptors Activated by the Ligand Translocate in the Nucleus to Enhance Osteoblast Transcription 139
High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes 138
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 131
Osteogenic differentiation of mesenchymal stem cells from dental bud: Role of integrins and cadherins 131
Stemness genes expression in naïve vs. osteodifferentiated human dental-derived stem cells 131
Bone Marrow Oxytocin Mediates the Anabolic Action of Estrogen on the Skeleton 129
Monoclonal antibodies for treating osteoporosis 129
The effects of bone pâté on human osteoblasts cell cultures 128
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 127
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 125
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 123
A new titanium biofunctionalized interface based on poly(pyrrole-3-acetic acid) coating: proliferation of osteoblast-like cells and future perspectives 123
Irisin Prevents Disuse-Induced Osteocyte Apoptosis 122
null 120
Role of Irisin on the bone-muscle functional unit 119
Osteotropic Cancers: From Primary Tumor to Bone 115
Mechanisms of Altered Bone Remodeling in Multiple Myeloma 115
FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis 114
In vitro osteoclastogenesis and bone resorption during spaceflight 113
Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts 111
THE ROLE OF LIGHT ON BONE REMODELING 109
A Novel Mechanism of Signal Transduction: Oxytocin Receptors Activated by the Ligand translocate in the Nucleus to enhance Osteoblast Specific Transcription 107
Oxytocin is an Anabolic Bone Hormone 107
Dominant gender-non-specific direct regulation of osteoblasts and osteoclasts by the pituitary hormone oxytocin 106
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 105
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 105
T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction 103
Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases 103
The effect of Irisin on bone cells in vivo and in vitro 103
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 102
High expression of TRAIL by osteoblastic differentiated dental pulp stem cells affects myeloma cell viability 101
Irisin for care and prevention of osteoporosis 101
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 100
Oxytocin: an estrogen-controlled autocrine-paracrine modulator of osteoclastogenesis and bone resorption 99
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 99
Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial 99
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 99
Skeleton and glucose metabolism: a bone-pancreas loop 98
Myokine Irisin and Its Effects Linking Bone and Muscle Function 98
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 98
Effects of extracorporeal shock waves on murine calvaria osteoblastic cells 97
The Role of LIGHT in Multiple Myeloma-Bone Disease 97
null 96
Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption 95
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 94
Irisin for care and prevention of osteoporosis 94
A novel interplay between irisin and PTH: from basic studies to clinical evidence in hyperparathyroidism 92
Oxytocin decreases bone resorption upregulating nitric oxide synthase isoforms 92
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 92
LIGHT as regulator of bone homeostasis during osteolytic bone metastasis formation in non-small cell lung cancer patients 91
Increased osteoclast activity in the presence of increased homocysteine concentrations 90
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma 90
Lack of oxytocin retards osteoblast differentiation and bone formation 89
Human osteoclasts express oxytocin receptor 89
Anatomy and physiology of skeletal tissue: The bone cells 89
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 89
T cells support the osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease 87
Irisin promotes growth, migration and matrix formation in human periodontal ligament cells 87
In vitro bone resorption during Spaceflight 86
null 86
null 85
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 84
Increased osteoclast differentiation and bone resorption during space flight 82
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 81
Anatomy and physiology of adipose tissue 81
Irisin Treatment Prevents Isoproterenol-Induced Cardiac Fibrosis in Mice 80
Bone Cells 80
Oxytocin Receptor Nuclear Translocation Could Be A Novel Mechanism Mediating Osteoblast Differentiation Induced By Oxytocin 78
Irisin and Secondary Osteoporosis in Humans 78
T cell-regulation of osteoclast formation and survival involving OPG/TRAIL interaction in an vitro model from human multiple myeloma 77
Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia 76
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 76
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 75
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 75
The myokine Irisin recapitulates the effect of physical activity on bone and muscle tissues 74
null 73
Irisin, the novel myokine responsible for benefits of physical exercise on bone 72
null 71
Irisin for care and prevention of osteoporosis 70
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 69
null 69
The role of light (TNFSF14) on bone remodeling 69
Totale 11.138
Categoria #
all - tutte 57.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.072 0 0 0 0 0 108 161 233 196 180 108 86
2021/2022959 71 85 10 29 45 82 28 37 96 68 163 245
2022/20231.366 181 169 97 88 135 190 33 156 233 14 29 41
2023/2024660 57 97 32 57 83 145 35 23 21 34 15 61
2024/20252.730 147 30 177 89 62 297 403 221 108 197 340 659
2025/20263.087 857 331 560 592 653 94 0 0 0 0 0 0
Totale 13.781